Skip to main content

Table 2 Microbiological data

From: An international survey on aminoglycoside practices in critically ill patients: the AMINO III study

Variables n
Microbiological sample (n = 930) 826 (89%)
Number of pathogens identified (n = 511)  
 1 317 (62%)
 2 121 (24%)
 3 and more 73 (14%)
Pathogens (n = 798)  
 Gram-positive bacteria 255 (32%)
  Staphylococcus/S. aureus 120 (15%)/84 (10.5%)
  Streptococci 64 (8%)
  Enterococci 67 (8.4%)
 Gram-negative bacteria 453 (58%)
  Escherichia coli 166 (21%)
  Klebsiella spp. 70 (8.8%)
  Pseudomonas aeruginosa 73 (9%)
  Enterobacter spp. 41 (5%)
  Acinetobacter baumannii 9 (1%)
  Stenotrophomonas maltophila 5 (0.6%)
 Anaerobes bacteria 24 (3%)
 Fungi/Candida 33 (4%)/31 (3.9%)
Susceptibility testing (n = 322)  
 AG susceptibility categories (S/I/R) 254 (79%)/14 (4%)/54 (17%)
  1. Results are given as numbers and percentages
  2. AG: aminoglycoside; MIC: minimal inhibitory concentration; R: resistant; I: intermediate; S: susceptible
\